Transgenomic, Inc. (OTCBB: TBIO) announced a new laboratory services partnership with the Guangzhou Family Planning Center of Guangzhou, China. Transgenomic will provide pharmacogenomic analyses in the Guangzhou Laboratory for pharmaceutical companies that are conducting clinical trials in China. China law requires that samples collected in China are tested in China. More details...

Stock Symbol: (OTCBB: TBIO)